Can Rosuvastatin prevent cardiovascular complications in patients with obesity, and how effective is it in addressing obesity-related lipid abnormalities?
Sahil KapoorExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer peopleβs questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Rosuvastatin effectively reduces LDL cholesterol and can prevent cardiovascular events in obese patients. It specifically addresses dyslipidemia associated with obesity.
Rosuvastatin is proven to lower ‘bad’ cholesterol levels, improving cardiovascular outcomes in obese individuals by managing lipid abnormalities effectively.